Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Clinical pharmacology of functional disorders of the urogenital system.

× No keyword cloud information.

17 in total

1. Effects of fesoterodine on the pharmacokinetics and pharmacodynamics of warfarin in healthy volunteers.

Authors: Bimal Malhotra; Christine Alvey; Jason Gong; Xiaoxi Li; Gregory Duczynski; Kuan Gandelman
Journal: Br J Clin Pharmacol Date: 2011-08 Impact factor: 4.335

Review 2. The forefront for novel therapeutic agents based on the pathophysiology of lower urinary tract dysfunction: alpha-blockers in the treatment of male voiding dysfunction - how do they work and why do they differ in tolerability?

Authors: Martin C Michel
Journal: J Pharmacol Sci Date: 2010-02-04 Impact factor: 3.337

Review 3. α1-Adrenoceptors and muscarinic receptors in voiding function - binding characteristics of therapeutic agents in relation to the pharmacokinetics.

Authors: Shizuo Yamada; Yoshihiko Ito; Hideo Tsukada
Journal: Br J Clin Pharmacol Date: 2011-08 Impact factor: 4.335

4. Comparison of pharmacokinetic variability of fesoterodine vs. tolterodine extended release in cytochrome P450 2D6 extensive and poor metabolizers.

Authors: Bimal Malhotra; Edress Darsey; Penelope Crownover; Juanzhi Fang; Paul Glue
Journal: Br J Clin Pharmacol Date: 2011-08 Impact factor: 4.335

5. Effects of the moderate CYP3A4 inhibitor, fluconazole, on the pharmacokinetics of fesoterodine in healthy subjects.

Authors: Bimal Malhotra; Maurice Dickins; Christine Alvey; Zhanna Jumadilova; Xiaoxi Li; Gregory Duczynski; Kuan Gandelman
Journal: Br J Clin Pharmacol Date: 2011-08 Impact factor: 4.335

6. A comprehensive non-clinical evaluation of the CNS penetration potential of antimuscarinic agents for the treatment of overactive bladder.

Authors: Ernesto Callegari; Bimal Malhotra; Peter J Bungay; Rob Webster; Katherine S Fenner; Sarah Kempshall; Jennifer L LaPerle; Martin C Michel; Gary G Kay
Journal: Br J Clin Pharmacol Date: 2011-08 Impact factor: 4.335

Clinical pharmacology of functional disorders of the urogenital system.

1. Effects of fesoterodine on the pharmacokinetics and pharmacodynamics of warfarin in healthy volunteers.

Review 2. The forefront for novel therapeutic agents based on the pathophysiology of lower urinary tract dysfunction: alpha-blockers in the treatment of male voiding dysfunction - how do they work and why do they differ in tolerability?

Review 3. α1-Adrenoceptors and muscarinic receptors in voiding function - binding characteristics of therapeutic agents in relation to the pharmacokinetics.

4. Comparison of pharmacokinetic variability of fesoterodine vs. tolterodine extended release in cytochrome P450 2D6 extensive and poor metabolizers.

5. Effects of the moderate CYP3A4 inhibitor, fluconazole, on the pharmacokinetics of fesoterodine in healthy subjects.

6. A comprehensive non-clinical evaluation of the CNS penetration potential of antimuscarinic agents for the treatment of overactive bladder.

Review 7. Alpha1-, alpha2- and beta-adrenoceptors in the urinary bladder, urethra and prostate.

8. Duloxetine in the treatment of stress urinary incontinence.

Review 9. Blood-brain barrier: ageing and microvascular disease--systematic review and meta-analysis.

10. Economic costs of overactive bladder in the United States.